Search Results | Clinicalinfo

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Search Results 2421 – 2440 of 3236

Guidelines Panel Members

https://clinicalinfo.hiv.gov/node/9171

https://clinicalinfo.hiv.gov/node/9172

Amprenavir (Agenerase, APV)

https://clinicalinfo.hiv.gov/node/9173

Cytomegalovirus Disease

https://clinicalinfo.hiv.gov/node/9174

Limitations to Treatment Safety and Efficacy

https://clinicalinfo.hiv.gov/node/9175

Adherence to the Continuum of Care

https://clinicalinfo.hiv.gov/node/9176

Considerations for Antiretroviral Use in People With Coinfections

https://clinicalinfo.hiv.gov/node/9178

Tuberculosis/HIV Coinfection

https://clinicalinfo.hiv.gov/node/9179

Appendix C: Key to Acronyms

https://clinicalinfo.hiv.gov/node/9180

Appendix C: Drug Name Abbreviations

https://clinicalinfo.hiv.gov/node/9181

Antepartum HIV Care

https://clinicalinfo.hiv.gov/node/9182

Indinavir (Crixivan, IDV)

https://clinicalinfo.hiv.gov/node/9187

Appendix A: Pediatric Antiretroviral Drug Information

https://clinicalinfo.hiv.gov/node/9188

Pharmacokinetic Enhancers

https://clinicalinfo.hiv.gov/node/9189

https://clinicalinfo.hiv.gov/node/9190

Appendix B: Acronyms

https://clinicalinfo.hiv.gov/node/9191

Laboratory Testing

https://clinicalinfo.hiv.gov/node/9192

Management of People With HIV and Antiretroviral Therapy Experience

https://clinicalinfo.hiv.gov/node/9193

Optimizing Antiretroviral Therapy in the Setting of Viral Suppression

https://clinicalinfo.hiv.gov/node/9194

Integrase Inhibitors

https://clinicalinfo.hiv.gov/node/9195